Use of low-dose quetiapine and the risk of major adverse cardiovascular events

被引：0
作者：
Hojlund, Mikkel [1 ]
Lund, Lars Christian [1 ]
Andersen, Kjeld [2 ]
Correll, Christoph U. [3 ]
Hallas, Jesper [4 ]
机构：
[1] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol Pharm & Environm Med, Odense, Denmark
[2] Mental Hlth Serv Region Southern Denmark, Dept Psychiat Odense, Odense, Denmark
[3] Zucker Hillside Hosp, Dept Psychiat, Glen Oaks, NY USA
[4] Univ Southern Denmark, Odense, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [1] The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events
    Ostergaard, Soren Dinesen
    Rohde, Christopher
    ACTA NEUROPSYCHIATRICA, 2023, 35 (01) : 1 - 2
  • [2] Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events
    Hojlund, Mikkel
    Andersen, Kjeld
    Ernst, Martin T.
    Correll, Christoph U.
    Hallas, Jesper
    ACTA NEUROPSYCHIATRICA, 2023, 35 (01) : 3 - 4
  • [3] Use of low-dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator-controlled cohort study
    Hojlund, Mikkel
    Andersen, Kjeld
    Ernst, Martin T.
    Correll, Christoph U.
    Hallas, Jesper
    WORLD PSYCHIATRY, 2022, 21 (03) : 444 - 451
  • [4] Low-dose Quetiapine for Major Depressive Disorder and Sleep Improvement
    Peters, Evyn M.
    Bowen, Rudy
    Balbuena, Lloyd
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (05) : 500 - 502
  • [5] Is Low Dose Beta Blocker Equivalent to High Dose for Reducing Major Adverse Cardiovascular Events?
    Allen, Jason E.
    Knight, Stacey
    McCubrey, Raymond O.
    Muhlestein, Joseph B.
    Lappe, Donald L.
    Goldberger, Jeffrey J.
    Anderson, Jeffrey L.
    CIRCULATION, 2015, 132
  • [6] Gastrointestinal adverse events compromise adherence to low-dose acetylsalicylic acid: a quantitative study in patients with cardiovascular risk
    Moberg, Christina
    Naesdal, Jorgen
    Svedberg, Lars Erik
    Duchateau, Delphine
    Harte, Nicola
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 : 47 - 47
  • [7] Low-dose prednisone increases the risk of adverse events in autoimmune hepatitis patients
    van den Brand, Floris
    de Boer, Ynto
    van Nieuwkerk, Karin
    Lissenberg-Witte, Birgit
    Bouma, Gerd
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E413 - E413
  • [8] The risk of major adverse cardiovascular events associated with the use of hypnotics in patients with insomnia
    El-Solh, Ali A.
    Lawson, Yolanda
    Wilding, Gregory E.
    SLEEP HEALTH, 2023, 9 (05) : 717 - 725
  • [9] Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the ElderlyAspirin in Reducing Events in the Elderly (ASPREE)
    Mark R. Nelson
    Christopher M. Reid
    Lawrence J. Beilin
    Geoffrey A. Donnan
    Colin I. Johnston
    Henry Krum
    Elsdon Storey
    Andrew Tonkin
    John J. McNeil
    Drugs & Aging, 2003, 20 : 897 - 903
  • [10] Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events
    Schmidt, Morten
    Johansen, Martin B.
    Robertson, Douglas J.
    Maeng, Michael
    Kaltoft, Anne
    Jensen, Lisette O.
    Tilsted, Hans-Henrik
    Botker, Hans E.
    Sorensen, Henrik Toft
    Baron, John A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (03) : 266 - 274
12345